Medbox, Inc. Files International PCT Application

Company files for global protection for patent pending technology

Dec 03, 2012, 09:14 ET from Medbox, Inc.

WEST HOLLYWOOD, Calif., Dec. 3, 2012 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (, announced today that it has filed a PCT application on its patent pending storage and retrieval lockbox system called the Lockbox Rx. The Patent Cooperation Treaty (PCT) enables the U.S. applicant to file one application, "an international application," in a standardized format in English in the U.S. Receiving Office (the U.S. Patent and Trademark Office), and have that application acknowledged as a regular national or regional filing in any State or region that is party to the PCT. This will extend the time for the company to file foreign patent applications, in any or all participating global jurisdiction of its choosing, until June 6, 2014 and still obtain credit for the earlier United States filing date. The underlying patent application is step upward from the company's approved medicine dispensing patent (US 7,844,363 B1).

The Lockbox Rx is a unique system that allows pharmacists to load a customer's medicine into a secure lockbox for later retrieval. The customer can pick up their medicine at their convenience through the self-service system by swiping their authorization card and placing their index finger on a scanner that compares the fingerprint to one taken at registration. Once the patient's identity has been verified, a lockbox door opens and they can access their medicine. 

The Lockbox Rx system also maintains a permanent record of each operation, including a photograph of every person conducting a transaction, thereby increasing security while virtually eliminating fraud.

The system is designed to lighten the pharmacist's workload while increasing their capacity and enhancing the customer experience. As a result, it functions as a "Pharmacist's Assistant."

"While we already have an issued patent on our primary model of medicine dispensing machine, elements of which are also contained in the Lockbox Rx, we feel that filing the PCT is a necessary step at this point to protect our global goals for automated prescription storage and retrieval under the supervision of licensed Pharmacists," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "The Lockbox Rx will revolutionize the ease in which patrons get their prescriptions in pharmacies while increasing safety, security, and inventory control."

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to

SOURCE Medbox, Inc.